When considered within a wider clinical context [60], our results suggest that a better fat storage capacity of adipose tissue depending on optimal levels of PPARγ and C/EBPα is essential for reducing the risk of hepatic steatosis. This evidence concerns the gene PPARG and fatty liver disease.